Login / Signup

Persistent symptoms 1.5-6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study.

Knut StavemWaleed GhanimaMagnus Kringstad OlsenHanne Margrethe GilboeGunnar Einvik
Published in: Thorax (2020)
This study assessed symptoms and their determinants 1.5-6 months after symptom onset in non-hospitalised subjects with confirmed COVID-19 until 1 June 2020, in a geographically defined area. We invited 938 subjects; 451 (48%) responded. They reported less symptoms after 1.5-6 months than during COVID-19; median (IQR) 0 (0-2) versus 8 (6-11), respectively (p<0.001); 53% of women and 67% of men were symptom free, while 16% reported dyspnoea, 12% loss/disturbance of smell, and 10% loss/disturbance of taste. In multivariable analysis, having persistent symptoms was associated with the number of comorbidities and number of symptoms during the acute COVID-19 phase.
Keyphrases
  • coronavirus disease
  • sars cov
  • sleep quality
  • liver failure
  • type diabetes
  • polycystic ovary syndrome
  • skeletal muscle
  • adipose tissue
  • pregnant women
  • insulin resistance
  • drug induced
  • respiratory failure